12 Panel Drug Test Cup with Adulterants – TCA & ADLTX

12 Panel Drug Test Cup with Adulterants and TCA

This 12 panel drug test cup with adulterants provides preliminary urine screening for 12 drugs or drug classes while also evaluating three specimen-validity characteristics. The exact panel configuration includes tricyclic antidepressants, or TCA, at a 1,000 ng/mL cutoff. It does not contain a PCP panel.

The integrated Serenity cup combines specimen collection, drug screening, a temperature strip and ADLTX indicators in one device. It is designed for organizations and testing programs that need a TCA configuration together with pH, specific gravity and creatinine indicators.

For other available configurations, browse our 12 panel drug test cup collection. If specimen-validity indicators are not required, compare this product with the 12 Panel TCA Test Cup without ADLTX.

Drugs and Cutoff Levels

These cutoff levels are used for preliminary screening. A screening result does not determine the amount consumed, the exact time of use, impairment or a clinical diagnosis. Refer to the current product insert for assay limitations and cross-reactivity information. Additional information is available in our drug test cutoff level guide.

How to Use the 12 Panel Drug Test Cup

1. Inspect the product: Verify the expiration date, sealed packaging and exact panel configuration before use.
2. Prepare the cup: Allow the sealed device to reach the temperature specified in the included instructions.
3. Collect the specimen: Have the donor provide urine directly into the collection cup.
4. Secure the lid: Close the lid completely and place the cup upright on a level surface.
5. Check the temperature strip: Review the specimen temperature within the period specified in the collection procedure.
6. Allow the panels to develop: Follow the development time stated in the current product insert.
7. Read the drug panels: Interpret the control and test lines within the specified reading window.
8. Review the ADLTX indicators: Compare the pH, specific gravity and creatinine pads with the supplied reference chart.

For visual examples and additional instructions, see how to read a drug test cup.

Understanding Drug Panel Results

• Negative: A control line and a test line appear for the panel. A faint test line should be interpreted according to the manufacturer’s instructions.
• Preliminary non-negative: The control line appears, but the corresponding test line does not appear.
• Invalid: The control line fails to appear. Repeat the screening process with a new device.

A preliminary non-negative result is not a definitive positive result. Appropriate confirmatory laboratory testing should be used when required by the testing policy, clinical procedure or applicable regulation.

CLIA Status and Product Verification

This product is currently listed within the CLIA-waived categories on DrugTestingCup.com. CLIA status applies to the exact device and configuration, not simply to the number of panels. Confirm the SKU and regulatory status printed on the current packaging before using the product in a CLIA-regulated testing program.

Organizations requiring a verified waived configuration can also review the available CLIA-waived drug test cups.

Bulk Ordering

This configuration is available for organizations that regularly purchase urine drug-screening supplies. Before placing a bulk order, confirm the exact drug panels, cutoff levels, ADLTX indicators, package quantity and regulatory status shown on the current product packaging.

Frequently Asked Questions

What does this 12 panel drug test cup screen for?

It screens for AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY, TCA and THC. It also includes pH, specific gravity and creatinine specimen-validity indicators.

Does this 12 panel cup include PCP?

No. This exact configuration contains TCA at a 1,000 ng/mL cutoff instead of PCP.

What do the ADLTX indicators measure?

The ADLTX indicators evaluate pH, specific gravity and creatinine. They provide information about specimen characteristics that may be associated with dilution, substitution or other specimen changes.

Do the ADLTX indicators count as additional drug panels?

No. This product contains 12 drug-screening panels. The three ADLTX indicators evaluate specimen validity and are not drug panels.

Do the ADLTX indicators prove that a specimen was adulterated?

No. They identify unusual specimen characteristics but do not independently prove intentional adulteration. Results should be interpreted according to the supplied chart and the organization’s testing procedure.

How should a preliminary non-negative result be handled?

A preliminary non-negative result should be handled according to the applicable testing policy. Confirmatory laboratory testing should be used when required.

Is bulk pricing available?

Yes. Quantity-based pricing is displayed on the product page. Select the required quantity to view the current unit price and order total.